QuidelOrtho Corporation
QDEL · NASDAQ
12/31/2024 | 12/29/2024 | 12/31/2023 | 1/1/2023 | |
|---|---|---|---|---|
| Revenue | $2,782,900 | – | $2,997,800 | – |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $1,496,400 | – | $1,503,400 | – |
| Gross Profit | $1,286,500 | – | $1,494,400 | – |
| % Margin | 46.2% | – | 49.8% | – |
| R&D Expenses | $218,700 | – | $246,800 | – |
| G&A Expenses | $0 | – | $748,100 | – |
| SG&A Expenses | $766,800 | – | $763,200 | – |
| Sales & Mktg Exp. | $0 | – | $15,100 | – |
| Other Operating Expenses | $2,261,900 | – | $345,300 | – |
| Operating Expenses | $3,247,400 | – | $1,355,300 | – |
| Operating Income | -$1,960,900 | – | $139,100 | – |
| % Margin | -70.5% | – | 4.6% | – |
| Other Income/Exp. Net | -$170,600 | – | -$168,200 | – |
| Pre-Tax Income | -$2,131,500 | – | -$29,100 | – |
| Tax Expense | -$79,500 | – | -$19,000 | – |
| Net Income | -$2,052,000 | – | -$10,100 | – |
| % Margin | -73.7% | – | -0.3% | – |
| EPS | -30.54 | – | -0.15 | – |
| % Growth | – | – | – | – |
| EPS Diluted | -30.54 | – | -0.15 | – |
| Weighted Avg Shares Out | 67,200 | – | 66,800 | – |
| Weighted Avg Shares Out Dil | 67,200 | – | 66,800 | – |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | – | $2,200 | – |
| Interest Expense | $188,300 | – | $178,900 | – |
| Depreciation & Amortization | $453,400 | – | $457,200 | – |
| EBITDA | -$1,489,800 | – | $607,000 | – |
| % Margin | -53.5% | – | 20.2% | – |